These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5645221)

  • 1. Reversible loss of activity of the first component of complement (C'1) as a function of ionic strength.
    Colten HR; Borsos T; Rapp HJ
    J Immunol; 1968 Apr; 100(4):799-807. PubMed ID: 5645221
    [No Abstract]   [Full Text] [Related]  

  • 2. Ultracentrifugation of the first component of complement: effects of ionic strength.
    Colten HR; Borsos T; Rapp HJ
    J Immunol; 1968 Apr; 100(4):808-13. PubMed ID: 4967046
    [No Abstract]   [Full Text] [Related]  

  • 3. Canine hemolytic complement: optimal conditions for its titration.
    Barta O; Barta V
    Am J Vet Res; 1973 May; 34(5):653-7. PubMed ID: 4634064
    [No Abstract]   [Full Text] [Related]  

  • 4. Feline (cat) hemolytic complement optimal testing conditions.
    Barta O; Oyekan PP
    Am J Vet Res; 1981 Mar; 42(3):378-81. PubMed ID: 6791533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A specific method for purification of the second component of guinea pig complement and a chemical evaluation of the one-hit theory.
    Mayer MM; Miller JA; Shin HS
    J Immunol; 1970 Aug; 105(2):327-41. PubMed ID: 5433696
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytotoxicity by stored human breast-milk: possible contribution of complement system.
    Ogundele MO
    Cell Biol Int; 1999; 23(8):585-8. PubMed ID: 10704243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new complement inhibitor in guinea pig serum.
    Okada H; Kawachi S; Nishioka K
    Jpn J Exp Med; 1969 Oct; 39(5):527-31. PubMed ID: 5309564
    [No Abstract]   [Full Text] [Related]  

  • 8. THE MACROMOLECULAR NATURE OF THE FIRST COMPONENT OF HUMAN COMPLEMENT.
    NAFF GB; PENSKY J; LEPOW IH
    J Exp Med; 1964 Apr; 119(4):593-613. PubMed ID: 14151101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of the first component of complement by zonal ultracentrifugation.
    Colten HR; Bond HE; Borsos T; Rapp HJ
    J Immunol; 1969 Oct; 103(4):862-5. PubMed ID: 4981689
    [No Abstract]   [Full Text] [Related]  

  • 10. [Action of calcium and magnesium ions on the arylesterase activity of erythrocytes modified by L-phenylaline].
    Balette JP; Nicot G
    C R Seances Soc Biol Fil; 1974; 168(6-7):743-6. PubMed ID: 4282040
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of c'1q, cations, and ionic strength in the formation of C'1 esterase.
    Ratnoff OD; Naff GB
    J Lab Clin Med; 1969 Sep; 74(3):380-8. PubMed ID: 4241158
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of the eighth component of complement (C8) by ethylenediaminetetra-acetate (EDTA).
    Schultz DR; Zarco RM
    J Immunol; 1970 Feb; 104(2):279-88. PubMed ID: 4983887
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficiency of the first component of complement (C'1) in the hemolytic reaction.
    Colten HR; Borsos T; Rapp HJ
    Science; 1967 Dec; 158(3808):1590-2. PubMed ID: 6060365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of plasma kallikrein with the C1 inhibitor.
    Gigli I; Mason JW; Colman RW; Austen KF
    J Immunol; 1970 Mar; 104(3):574-81. PubMed ID: 5435787
    [No Abstract]   [Full Text] [Related]  

  • 15. COMPLEMENT AS A MEDIATOR OF INFLAMMATION. ENHANCEMENT OF VASCULAR PERMEABILITY BY PURIFIED HUMAN C'1 ESTERASE.
    RATNOFF OD; LEPOW IH
    J Exp Med; 1963 Nov; 118(5):681-98. PubMed ID: 14087615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. THE ELUTION OF S35-LABELLED C'1 FROM ANTIGEN-ANTIBODY-S35 COMPLEMENT PRECIPITATES.
    KORNFELD L; WEIGLE WO
    Immunology; 1965 Feb; 8(2):213-20. PubMed ID: 14295645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of the irradiation conditions on the radiation inactivation of subtilisin-72].
    Orlova MA; Nikol'skaia II; Bogaevskaia EV; Golubtsov IV
    Radiobiologiia; 1986; 26(6):844-6. PubMed ID: 3544014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extraction of complement inhibitory factors from the erythrocytes of non-human species.
    Hoffmann EM; Etlinger HM
    J Immunol; 1973 Sep; 111(3):946-51. PubMed ID: 4741303
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of ionic strength, temperature, and antibody class and avidity on fixation and transfer of the first component of complement.
    Linscott WD
    J Immunol; 1969 Apr; 102(4):993-1001. PubMed ID: 5768200
    [No Abstract]   [Full Text] [Related]  

  • 20. Sodium azide inhibition of complement-mediated functions.
    Shaw DR; Shaw MW; Hickman SE; Lamon EW; Griffin FM
    Immunology; 1980 Jan; 39(1):53-6. PubMed ID: 7380463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.